CSIMarket
 


Cognition Therapeutics inc   (CGTX)
Other Ticker:  
 

Cumulative Cognition Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

CGTX's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CGTX Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -32.08 % 16.08 % -2.35 % -0.88 % 173.62 %
Y / Y Cash & cash equivalent Growth -29.27 % -18.75 % -24.65 % -24.05 % 460.89 %
Quick Ratio for Trailing Twelve Months Period 4.79 4.65 5.05 5.4 5.77
Total Ranking # 478 # 564 # 599 # 660 # 629
Seq. Current Liabilities Growth 3.98 % 6.01 % -4.23 % -35.66 % 77.71 %
Seq. Cash & cash equivalent Growth -11.35 % -4.17 % -6.62 % -10.83 % 1.83 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Current Liabilities decreased faster than Cognition Therapeutics Inc 's average Cash & cash equivalent, this led to increase in in Cognition Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period to 4.79, Quick Ratio for Trailing Twelve Months Period remained below Cognition Therapeutics inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 90 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Cognition Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about CGTX
Quick Ratio CGTX in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 91
Sector # 397
S&P 500 # 582


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.99 5.11 4.12
(Jun 30 2022)   (Mar 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Voyager Therapeutics Inc   12.73 
Achilles Therapeutics Plc  12.56 
Cardiff Oncology inc   12.40 
Rubius Therapeutics Inc   11.94 
Ikena Oncology Inc   11.74 
Springworks Therapeutics Inc   11.12 
Aim Immunotech Inc   10.97 
Scholar Rock Holding Corp  10.56 
Invivyd Inc   10.51 
Allogene Therapeutics inc   10.40 
Century Therapeutics inc   10.35 
Monte Rosa Therapeutics Inc   10.29 
Ambrx Biopharma Inc   10.26 
Organovo Holdings Inc   10.07 
Avrobio Inc   10.06 
Caribou Biosciences Inc   9.83 
Iteos Therapeutics Inc   9.70 
Athira Pharma Inc   9.52 
Solid Biosciences Inc   9.45 
Vectivbio Holding Ag  8.95 
Autolus Therapeutics Plc  8.90 
Immunovant Inc   8.82 
Allovir Inc   8.81 
Jasper Therapeutics Inc   8.73 
Passage Bio inc   8.63 
Candel Therapeutics Inc   8.62 
Elevation Oncology inc   8.56 
Inhibrx Inc   8.50 
Humacyte Inc   8.41 
Surrozen Inc   7.97 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com